rs1114167531
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_001370259.2(MEN1):c.1382_1389dupAGGCCGAG(p.Ala464ArgfsTer98) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_001370259.2 frameshift
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MEN1 | NM_001370259.2 | c.1382_1389dupAGGCCGAG | p.Ala464ArgfsTer98 | frameshift_variant | Exon 10 of 10 | ENST00000450708.7 | NP_001357188.2 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 43
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Multiple endocrine neoplasia, type 1 Pathogenic:1
This sequence change results in a premature translational stop signal in the MEN1 gene (p.Ala464Argfs*98). While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 147 amino acids of the MEN1 protein. This variant is not present in population databases (ExAC no frequency). This variant has been reported in an individual affected with multiple endocrine neoplasia type 1 (PMID: 12050235). ClinVar contains an entry for this variant (Variation ID: 428075). This frameshift disrupts the functionally conserved nuclear localization signal of the MEN1 protein. Experimental studies have shown that disruption of this region abrogates the ability of MEN1 to bind DNA, regulate target gene expression, and inhibit cell proliferation (PMID: 15331604, 16449969). In addition, a different frameshift variant (p.Arg516Glyfs*43) with a premature termination codon downstream of this frameshift has been reported to be a common cause of multiple endocrine neoplasia type 1 (PMID: 17879353) For these reasons, this variant has been classified as Pathogenic. -
Hereditary cancer-predisposing syndrome Pathogenic:1
The c.1382_1389dupAGGCCGAG pathogenic mutation, located in coding exon 9 of the MEN1 gene, results from a duplication of AGGCCGAG at nucleotide position 1382, causing a translational frameshift with a predicted alternate stop codon (p.A464Rfs*98). This same 8 base pair duplication, referred to as "fs 96 aa X", was detected in 1 of 34 unrelated MEN1 probands (Turner JJ, J. Clin. Endocrinol. Metab. 2002 Jun; 87(6):2688-93). This alteration is expected to result in loss of function by premature protein truncation. As such, this alteration is interpreted as a disease-causing mutation. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at